2023, Number 2
<< Back Next >>
Aten Fam 2023; 30 (2)
Association Between Depressive Symptoms and Metabolic Syndrome in People Over 45 Years of Age
De Alba-Melchor JS, Chacón-Valladares P, Lajud-Ávila N
Language: Spanish
References: 32
Page: 153-159
PDF size: 160.43 Kb.
ABSTRACT
Objective: To determine the frequency
of depressive symptoms and metabolic
syndrome in patients over 45 years of
age, as well as their possible associations.
Methods: analytical cross-sectional
study. 120 participants assigned to Family
Medicine Unit No. 80 of the Mexican
Institute of Social Security were included.
Depressive symptoms were assessed
using the Beck Depression Inventory-II.
Participants’ anthropometric measurements
were analyzed; fasting glucose
concentration, triglycerides, and HDL
cholesterol in blood. Pearson’s χ
2 analysis
was performed to test for differences in
dichotomous qualitative variables and
odds ratio was used to calculate risk
with a 95% confidence interval.
Results:
the frequency of metabolic syndrome
was 93.3%, of which 51.7% reported
depressive symptoms. The frequency
of depressive symptoms was higher in
women than in men (MR= 2.1, 95%
CI:1.2- 3.7,
p= 0.009). Neither association
was observed between depressive symptoms
or metabolic syndrome, nor with its
components.
Conclusion: the frequency
of metabolic syndrome in the studied
population was higher than the previously
reported and 53.3% of people with
metabolic syndrome reported depressive
symptoms; these were more frequent in
women, and showed no association with
metabolic syndrome.
REFERENCES
Palacios A, Durán M, Obregón O. Factores deriesgo para el desarrollo de diabetes tipo 2 y síndromemetabólico. Rev Venez Endocrinol Metab. 2012;10(1):34-40.
Lamichhane DK, Heo YS, Kim HC. DepressiveSymptoms and Risk of Absence Among Workers ina Manufacturing Company: a 12-Month Follow-Up Study. Ind Health. 2018;56(3):187-197.
Macías SA, Villarreal PHJ. Sostenibilidad delgasto público: cobertura y financiamiento de enfermedadescrónicas en México. Ens Rev Econ.2018;37(1):99-133.Alba-Melchor J. y cols.Aten Fam. 2023;30(2):153-159. http://dx.doi.org/10.22201/fm.14058871p.2023.2.85033
Goldbacher EM, Bromberger J, Matthews KA. Lifetimehistory of major depression predicts the developmentof the metabolic syndrome in middle-agedwomen. Psychosom Med 2009;71(3):266-72.
Ortíz MS, Sapunar J. Estrés psicológico y síndromemetabólico. Rev Méd Chile. 2018;146(11):1278-1285.
Bahar A, Kashi Z, Kheradmand M, Hedayatizadeh-Omran A, Moradinazar M, Ramezani F, et al. Prevalenceof metabolic syndrome using internationaldiabetes federation, National Cholesterol EducationPanel- Adult Treatment Panel III and Iranian criteria:results of Tabari cohort study. J Diabetes MetabDisord. 2020;19(1):205-211.
Capapey J, Parellada E. El trastorno depresivo enAtención Primaria. Med Integr. 2002;40(6):256-266.
Ansoleaga ME, Miranda-Hiriart G. Depresión ycondiciones de trabajo: revisión actualizada de la investigación.Rev Costarric Psicol. 2014;33(1):1-14.
Wagner FA, González-Forteza C, Sánchez-GarcíaS, García-Peña C, Gallo JJ. Enfocando la depresióncomo problema de salud pública en México. SaludMent. 2012;35(1):3-11.
Besedovsky HO, del Rey A. Immune - neuro - endocrineinteractions: facts and hypotheses. EndocrRev. 1996;17(1):64-102.
Zanoveli JM, Morais Hd, Dias IC, Schreiber AK,Souza CP, Cunha JM. Depression associated withdiabetes: from pathophysiology to treatment. CurrentDiab Rev. 2016;12(3):165-178.
Shoelson SE, Lee J, Goldfine AB. Inflammation andinsulin resistance. J Clin Invest. 2006;116(8):1793-1801.
Whitworth JA, Williamson PM, Mangos G, KellyJJ. Cardiovascular consequences of cortisol excess.Vasc Health Risk Manag. 2005;1(4):291-299.
Korten NC, Comijs HC, Lamers F, Penninx BW.Early and late onset depression in young andmiddle aged adults: differential symptomatology,characteristics and risk factors? J Affect Disord.2012;138(3):259-67.
Park YW, Zhu S, Palaniappan L, Heshka S, CarnethonMR, Heymsfield SB. The metabolic syndrome:prevalence and associated risk factor findings inthe US Population from the Third National Healthand Nutrition Examination Survey, 1988-1994.Arch Intern Med. 2003;163(4):427-436.
Zambrano E, Reyes-Castro LA, Nathanielsz PW.Aging, glucocorticoids and developmental programming.Age (Dordr). 2015;37(3):9774.
McEwen BS. Sex, stress and the hippocampus: allostasis,allostatic load and the aging process. NeurobiolAging. 2002;23(5):921-39.
López CSM, Alveano HJ, Carranza MJ. Prevalenciade síntomas depresivos en síndrome metabólico.Rev Fac Nac Salud Pública. 2008;26(2):124-133.
Zimmet P, Albertib KG, Serrano RM. Una nuevadefinición mundial del síndrome metabólicopropuesta por la Federación Internacional de Diabetes:fundamento y resultados. Rev Esp Cardiol.
2005;58(12):1371-1376.20. González DA, Reséndiz RA, Reyes-Lagunes I.Adaptation of the BDI-II in Mexico. Salud Ment.2015;38(4):237-244.
Wacher-Rodarte N. II. Epidemiología del síndromemetabólico. Gac Med Mex. 2009;145(5):384-391
Rojas-Martínez R, Aguilar-Salinas CA, Romero-Martínez M, Castro-Porras L, Gómez-Velasco D,Mehta R. Trends in the prevalence of metabolicsyndrome and its components in Mexican adults,2006-2018. Salud Publica Mex. 2021;63:713-724
Aguilar-Salinas CA, Rojas R, Gómez-Pérez FJ, VallesV, Ríos-Torres JM, Franco A, et al. High prevalenceof metabolic syndrome in Mexico. Arch MedRes. 2004;35(1):76-81.
Gutiérrez-Solis AL, Datta Banik S, Méndez-GonzálezRM. Prevalence of Metabolic Syndrome inMexico: A Systematic Review and Meta-Analysis.Metab Syndr Relat Disord. 2018;16(8):395-405.
Shamah-Levy T, Vielma-Orozco E, Heredia-HernándezO, Romero-Martínez M, Mojica-Cuevas J,Cuevas-Nasu L, et al. Encuesta Nacional de Salud yNutrición 2018 - 19: Resultados Nacionales. Cuernavaca,México: Instituto Nacional de Salud Pública,2020.
Ocampo M, Santa C. Salud Mental en México. INCyTU.2018;(7):1-6.
Martínez-Mendoza MC, Gutiérrez-Mendía A,Bonaparte-Caballero E, Gómez-Alonso C, LajudN. Prevalencia de Depresión en Adultos Mayores enuna Unidad de Medicina Familiar de Michoacán.Aten Fam. 2021;28(2):118-124
Morales-Ramírez D, Martínez-Lara V, Reyna-Castillo,MA. Depresión, Ansiedad y Estrés en Usuariosde Atención Primaria durante el Confinamientopor Coronavirus. Rev Med Inst Mex Seguro Soc.2021;59(5):387-94.
Jiang B, Zheng Y, Chen Y, Chen Y, Li Q, Zhu C, etal. Age and gender-specific distribution of metabolicsyndrome components in East China: role of hypertriglyceridemiain the SPECT-China Study. LipidsHealth Dis. 2018;17(1):92.
Kuk JL, Ardern CI. Age and sex differences inthe clustering of metabolic syndrome factors:association with mortality risk. Diabetes Care.2010;33(11):2457-61.
Martínez VMA, Hernández MMB, Godínez TED.Depresión en un grupo de pacientes con DiabetesMellitus Tipo 2 en una Clínica Regional del Municipiode Jilotepec, México. Aten Fam. 2012;19(3):58-60.
Wen Y, Liu G, Shang Y, Wang Q. Association ofDepression with Metabolic Syndrome in HighlyEducated Ethnic Koreans of China: A Case-ControlStudy. Neuropsychiatr Dis Treat. 2021;17:57-66.